You have 9 free searches left this month | for more free features.

long-acting rilpivirine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

Not yet recruiting
  • HIV-1-infection
  • +2 more
  • CAB + RPV
  • (no location specified)
Nov 16, 2022

Long-acting Injectable Cabotegravir + Rilpivirine

Not yet recruiting
  • Patient Satisfaction
  • +3 more
    • Santiago, Region Metropolitana, Chile
      CICUC
    Apr 18, 2023

    HIV-1-infection Trial (Etonogestrel (ENG) Subdermal Implants)

    Not yet recruiting
    • HIV-1-infection
    • Etonogestrel (ENG) Subdermal Implants
    • (no location specified)
    Jul 19, 2022

    HIV Trial in Glendale (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir extended release suspension for injection

    Completed
    • HIV Infections
    • Cabotegravir Tablets
    • +3 more
    • Glendale, California
      GSK Investigational Site
    Feb 14, 2022

    HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

    Not yet recruiting
    • HIV Infections
    • (no location specified)
    Jun 13, 2023

    HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)

    Not yet recruiting
    • HIV-1-infection
    • Once daily CAB tablet + RPV tablet
    • Long acting CAB injectable + long acting RPV injectable
    • Atlanta, Georgia
    • +11 more
    Dec 13, 2022

    Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

    Recruiting
    • Human Immunodeficiency Virus
    • Opioid Use Disorder
    • Combined LAI Treatment: Cabenuva and Sublocade
    • Providence, Rhode Island
      Rhode Island Hospital
    Aug 7, 2023

    HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

    Recruiting
    • HIV Infections
    • Oral Cabotegravir (CAB)
    • +4 more
    • La Jolla, California
    • +30 more
    Feb 2, 2023

    HIV-positive People, Treated With Long Acting Antiretroviral

    Active, not recruiting
    • HIV Infections
    • Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL
    • Milan, Italy
      Ospedale San Raffaele Scientific Institute
    Dec 15, 2022

    HIV Trial in Boston (CAB-RPV LA, Standard treatment within an HIV clinic)

    Enrolling by invitation
    • HIV Infections
    • CAB-RPV LA
    • Standard treatment within an HIV clinic
    • Boston, Massachusetts
    • +1 more
    Feb 24, 2022

    HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)

    Active, not recruiting
    • HIV Infections
    • CAB LA
    • +3 more
    • Phoenix, Arizona
    • +29 more
    Jan 22, 2023

    HIV-1-infection, Medication Adherence, Satisfaction, Patient Trial in Little Rock (Home visit delivery strategy)

    Recruiting
    • HIV-1-infection
    • +2 more
    • Home visit delivery strategy
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Oct 20, 2022

    Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable

    Completed
    • Human Immunodeficiency Virus Type 1 (HIV-1)
    • Cabotegravir Injectable Suspension
    • Rilpivirine Injectable Suspension
    • Bakersfield, California
    • +31 more
    May 31, 2023

    HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular

    Recruiting
    • HIV Infections
    • +2 more
    • Cabotegravir/ Rilpivirine
    • +4 more
    • Eldoret, Kenya
      Academic Model Providing Access to Healthcare (AMPATH) Moi Teach
    Mar 30, 2022

    Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

    Active, not recruiting
    • Human Immunodeficiency Virus Type 1 (HIV-1)
    • Cabotegravir - Injectable Suspension (CAB LA)
    • Rilpivirine - Injectable Suspension (RPV LA)
    • Macon, Georgia
    • +29 more
    May 31, 2023

    HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)

    Recruiting
    • HIV Infections
    • Standard of Care (SOC) Oral ART
    • +6 more
    • Birmingham, Alabama
    • +34 more
    Dec 1, 2021

    HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

    Active, not recruiting
    • HIV Infections
    • Cabotegravir Tablets
    • +4 more
    • Bakersfield, California
    • +116 more
    Jan 22, 2023

    HIV Trial in Worldwide (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir Injectable Suspension)

    Active, not recruiting
    • HIV Infections
    • Cabotegravir Tablets
    • +3 more
    • Birmingham, Alabama
    • +118 more
    Jul 14, 2021

    Cisgender Female Patients Who Start on Long Acting Cabotegravir

    Not yet recruiting
    • Hiv
    • Cabotegravir Injection [Apretude]
    • Orlando, Florida
    • +2 more
    Nov 17, 2023

    Opioid Use Disorder Trial (naltrexone implant)

    Not yet recruiting
    • Opioid Use Disorder
    • naltrexone implant
    • (no location specified)
    Dec 7, 2022

    Moderate Asthma Trial (Long-Acting Beta Agonist)

    Not yet recruiting
    • Moderate Asthma
    • Long-Acting Beta Agonist
    • (no location specified)
    Feb 24, 2023

    Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)

    Not yet recruiting
    • Schizophrenia
    • Schizoaffective Disorder
    • (no location specified)
    Mar 24, 2023

    Implementation and Delivery of Cabotegravir Long Acting

    Not yet recruiting
    • HIV Infections
    • Cabotegravir Injection [Apretude]
    • Seattle, Washington
    • +1 more
    May 16, 2023

    Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

    Not yet recruiting
    • Copd
    • SABA SAMA ICS Vs LABA LAMA ICs
    • Assiut, Egypt
      Nermen Mohammed Abuelkassem
    Feb 28, 2023